Acute Myeloblastic Leukemia Type 1

Search Trials
Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia
Status:
Completed
Last Changed:
Dec 8, 2021
First Changed:
Dec 8, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Cholecalciferol 2800 I.U. ml oral drops
Phase 1 Study of Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Status:
Not yet recruiting
Last Changed:
Feb 9, 2022
First Changed:
Jan 12, 2022
Disease(s):
Acute Myeloid Leukemia (AML)
Intervention(s):
Niclosamide
Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine in Patients With Acute Myeloid Leukemia
Status:
Suspended
Last Changed:
Feb 17, 2022
First Changed:
Feb 3, 2017
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
DecitabineNavtemadlin
Ph1 Trial Test Safety of IL-21 NK Cells for Induction of R/R AML
Status:
Recruiting
Last Changed:
Feb 18, 2022
First Changed:
Jan 7, 2020
Disease(s):
Allogeneic Stem Cell Transplant Recipient
Intervention(s):
Cytarabine HydrochlorideFludarabineMembrane-bound Interleukin-21-Expanded Haploidentical Natural Killer Cells
Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia
Status:
Recruiting
Last Changed:
Dec 2, 2021
First Changed:
Oct 4, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Arm 1: NTLA-5001Arm 2: NTLA-5001

Connect. Empower. Inspire.